Allergan, Inc Patent Portfolio Statistics
Profile Summary
This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.
How does the overall patent portfolio of Allergan, Inc. look like?
Assignee | Art Units | |
Total Applications: | 2,781 | 1,912,264 |
Granted Patents: | 1,758 | 1,012,365 |
Grant Index | 66.95% ↑ | 66.82% |
Abandoned/Rejected Applications: | 868 (33.05%) | 502,634 (33.18%) |
In-Process Applications: | 152 | 397,265 |
Average Grant Time: | 2.73 Years ↓ | 2.81 Years |
Average Office Actions: | 1.77 ↑ | 1.74 |
Which Technology Area Allergan, Inc. is filing most patents in? (Last 10 years)
Art Unit | Definition | Total Applications |
1626 | Organic Chemistry | 218 |
1645 | Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology | 166 |
1627 | Organic Chemistry | 115 |
1625 | Organic Chemistry | 113 |
1617 | Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs | 109 |
How many patents are Allergan, Inc. filing every year?
Year | Total Applications | Predicted |
2022 | 0* | 578 |
2021 | 23* | 509 |
2020 | 13 | 388 |
2019 | 43 | 43 |
2018 | 53 | – |
2017 | 77 | – |
2016 | 95 | – |
2015 | 131 | – |
2014 | 213 | – |
2013 | 256 | – |
*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published
Recently filed patent applications of Allergan, Inc. in USPTO?
Application number: 15/353,262
Abstract:
Publication date: 2017-04-06
Applicant: Allergan, Inc.
Inventors: Dibas I Mohammed
Publication number: US20160310416A1
Application number: 15/048,607
Abstract:
Publication date: 2016-10-27
Applicant: Allergan, Inc.
Inventors: Bakhit Peter
Publication number: None
Application number: 61/709,854
Abstract:
–
Publication date: –
Applicant: Allergan, Inc.
Inventors: Li Ling
How are Allergan, Inc.’s applications performing in USPTO?
Application Number | Title | Status | Art Unit | Examiner |
15/353,262 | Pharmaceutical Compositions Comprising 7-(1H-Imidazol-4-Ylmethyl)-5,6,7,8-Tetrahydro-Quinoline For Treating Skin Diseases And Conditions | Abandoned — Failure to Respond to an Office Action | 1627 | Karol, Jody Lynn |
15/048,607 | Compositions Containing Alpha-2-Adrenergic Agonist Components | Patented Case | 1612 | Packard, Benjamin J |
61/709,854 | Bicyclic 1, 2, 4-Oxadiazoles Derivatives As Sphingosine-1 Phosphate Receptors Modulators | Provisional Application Expired | – | – |